Regenxbio Inc (RGNX)
Current ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 334,971 | 415,976 | 518,826 | 531,197 | 345,032 |
| Total current liabilities | US$ in thousands | 130,272 | 130,434 | 130,472 | 81,447 | 33,676 |
| Current ratio | 2.57 | 3.19 | 3.98 | 6.52 | 10.25 |
December 31, 2023 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $334,971K ÷ $130,272K
= 2.57
The current ratio of Regenxbio Inc has shown a declining trend over the past five years. As of December 31, 2023, the current ratio stands at 2.57, down from 3.19 in 2022, 3.98 in 2021, 6.52 in 2020, and 10.25 in 2019.
The decreasing current ratio indicates a reduction in the company's ability to cover its short-term obligations with its current assets. A current ratio above 1 typically suggests that the company can meet its current liabilities using its current assets, but the downward trend raises some concern.
It's important to further investigate the reasons behind this decline in the current ratio and assess whether it is due to changes in the company's current assets, current liabilities, or a combination of both. Additionally, monitoring the trend over the next few reporting periods will be crucial to understanding the company's liquidity position.
Peer comparison
Dec 31, 2023